Dietary supplementation with L-arginine fails to restore endothelial function in Forearm resistance arteries of patients with severe heart failure

Journal of the American College of Cardiology

Volumn 27, Issue 5, 1996, Pages 1207-1213

  Chin Dusting, Jaye P F ^a,b   Kaye, David M ^a   Lefkovits, Jeffrey ^a   Wong, James ^a   Bergin, Peter ^a   Jennings, Garry L ^a  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; NITROPRUSSIDE SODIUM; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOREARM; HEART FAILURE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0029871489     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00611-7     Document Type: Article

References (40)

1. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21.
2. Leimbach WN, Wallin GB, Victor RG, Aylward PE. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-9.
3. Francis GS, Rector RS, Cohn JN. Sequential neurohumoral measurements in patients with congestive heart failure. Am Heart J 1988;116:1464-8.
4. Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 1983;1:1385-90.
5. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
6. Drexler H, Hayoz D, Munzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1595-1601.
7. Angus JA, Ferrier CP, Sudhir K, Kaye DM, Jennings G. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc Res 1993;27:204-10.
8. Elsner D, Muntze A, Kromer EP, Riegger GAJ. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res 1991;25:438-40.
9. Ontekan M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991;69:1088-96.
10. Kaye DM, Jennings G, Angus JA. Endothelium dependent vasodilation is impaired in experimental cardiomyopathy. Clin Exp Physiol Pharmacol 1994;21:709-19.
11. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-70.
12. Hirooka Y, Imaizumi T, Tagawa T, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658-68.
13. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-50.
14. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolaemic humans. J Clin Invest 1992;90:1248-53.
15. Rose WC. The nutritive significance of the amino acids and certain related compounds. Science 1937;86:298-300.
16. Kline JJ, Hug G, Schubert WK, Berry H. Arginine deficiency syndrome. Am J Dis Child 1981;135:437-42.
17. Barbul A. Arginine: biochemistry, physiology and therapeutic implications. J Parenteral Enteral Nutrition 1986;10:227-38.
18. DeAloysio D, Mantuano R, Mauloni M. The clinical use of arginine aspartate in male infertility. Acta Eur Fertil 1982;13:133-67.
19. Gibbs JS, Keegan J, Wright C, Fox KM, Poole-Wilson PA. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 1990;15:62-3.
20. Chin JPF, Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993;21:22-8.
21. Chin JPF, Gust AP, Dart AM. Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo. J Hypertension 1993;11:1229-34.
22. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
23. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.
24. Hirooka Y, Imaizumi T, Harada S, et al. Endothelium-dependent forearm vasodilation to acetylcholine but not to substance P is impaired in patients with heart failure. J Cardiovasc Pharmacol 1992;20:221-5.
25. Rubanyi G, Vanhoutte P. Endothelium removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 1985;7:139-44.
26. Pohl U, Dezsi L, Simon B, Busse R. Selective inhibition of endothelium-dependent dilation in resistance-sized vessels in vivo. Am J Physiol 1987; 253:H234-9.
27. Hori M, Kitikaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991;18:565-74.
28. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in the endothelium-dependent relaxation. Biochem Biophys Res Com̀mun 1988;153:1251-6.
29. Imaizumi T, Hirooka Y, Masaki H, et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-7.
30. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun 1989;164:714-21.
31. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-5.
32. Brusilow SW, Batshaw ML. Arginine therapy of argininosuccinase deficiency. Lancet 1979;1:124-7.
33. Jungling ML, Bunge RD. The treatment of spermatogenic arrest with arginine. Fertil Steril 1976;27:282-3.
34. Bushinsky DA, Gennari FJ. Life-threatening hyperkalemia induced by arginine. Ann Intern Med 1978;89:632-4.
35. White MF, Christensen HN. Simultaneous regulation of an amino acid influx and efflux by system A in the hepatoma cell HPC. J Biol Chem 1983;258: 8028-38.
36. Milne MD, Asatoor AM, Edwards KDG, Loughridge LW. The intestinal absorption defect in cystinuria. Gut 1961;2:323-37.
37. Castillo L, DeRojas TC, Chapman TE, et al. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993;90:193-7.
38. Gullino P, Birnbaum SM, Winitz M, Greenstein JP. Studies on the metabolism of amino acids and related compounds in vivo. VIII. Influence of the route of administration of L-arginine HCl on protecting rats against ammonia toxicity. Arch Biochem Biophys 1958;76:430-8.
39. Adams MR, Forsyth C, Robinson C, Jessup W, Celermajer DS. Oral L-arginine in humans: effects on platelet aggregation, hemodynamics and endothelium-dependent dilatation [abstract]. Circulation 1995;90 Suppl I:I-138.
40. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation 1994;89:1615-23.